fb_script

Results from the Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT)

The international AdDIT trial group have this month published results of a four year clinical trial in The New England Journal of Medicine, finding that ACE inhibitors and statins did not change the primary outcome – the albumin to creatinine ratio – compared to placebo in adolescents with type 1 diabetes (T1D).  Read More

Children with type 1 diabetes at risk of acute kidney injury following DKA

A new study has found that children with type 1 diabetes (T1D) who are hospitalised for Diabetic Ketoacidosis (DKA) are more likely to develop acute kidney injury (AKI), a sudden episode of renal failure or damage. DKA is a severe complication that occurs with prolonged hyperglycaemia. It may occur at the initial presentation of newly diagnosed T1D or in someone with pre-existing T1D in times of illness or insulin omission.
Read More

Australian diabetes expert receives Australia Day honour

JDRF is proud to congratulate Professor Mark Cooper, Head of Diabetes in the Faculty of Medicine, Nursing and Health Sciences at Monash University, who was awarded an AO (Officer in the General Division of the Order of Australia) on Australia Day this month.

imageedit_1_3004952851

This award is the most prestigious means of recognising outstanding members of the community at a national level.

Read More

Australian diabetes expert recognised with prestigious international award

JDRF-funded researcher Professor Mark Cooper, Chief Scientific Officer and Head of the Diabetes Division at Baker IDI Heart and Diabetes Research Institute, has become the first Australian to receive the prestigious Claude Bernard award from the European Association for the Study of Diabetes this month.  Read More

T1DCRN awards $14 million for type 1 diabetes clinical research

The Type 1 Diabetes Clinical Research Network (T1DCRN) announced today that over $14 million in grants have been awarded to Australian researchers for clinical research projects commencing in 2016.

RFA1 Announcement 090915

This funding forms part of the $35 million funding awarded to the T1DCRN by the Australian Research Council, and will support five innovative programs targeting a broad range of T1D research areas including: Read More

A new individualised approach to severe hypoglycaemia

T1DCRN researcher Professor Thomas Kay from St Vincent’s Institute in Melbourne and an international team of specialists have developed a new four-stage treatment plan to tackle problematic hypoglycaemia.

fingerprick

Severe hypoglycaemia is experienced by a third of people with type 1 diabetes at least once per year, when they will require another person to assist them in recovery. Severe hypoglycaemia can usually be explained by exercise, alcohol or errors in insulin dose, but in some people it is unpredictable and can occur seemingly without explanation.  This problematic hypoglycaemia has significant impacts on health and quality of life, but can be difficult to treat. Read More

Rapid stomach emptying in teenagers with T1D

A study at the Women’s and Children’s Hospital in Adelaide has shown that adolescents with type 1 diabetes have a faster than normal gastric (stomach) emptying time. This rapid digestion of carbohydrate-containing meals can lead to higher blood glucose levels after eating, impacting long-term blood glucose control.

teenagemeals

The study compared the gastric emptying time of 30 adolescents with T1D with age- and sex-matched controls following a standardised meal. The median time taken for half of the meal to be emptied from the stomach was 78 minutes in adolescents with T1D, compared with 109 minutes in controls.  Faster gastric emptying resulted in higher blood glucose levels after the meal. Read More